DTIL - Precision BioSciences, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
25,098
25,098
115,529
24,285
22,238
Operating expenses
Research development
83,939
83,939
115,238
98,061
82,416
Selling general and administrative
41,525
41,525
39,693
36,052
27,026
Total operating expenses
125,464
125,464
154,931
134,113
109,442
Operating income or loss
-100,366
-100,366
-39,402
-109,828
-87,204
Interest expense
1,111
1,111
132
0
182
Total other income/expenses net
-13,633
-13,633
8,724
-
-9,758
Income before tax
-111,637
-111,637
-30,602
-109,006
-92,877
Income from continuing operations
-111,637
-111,637
-30,602
-109,006
-92,877
Net income
-111,637
-111,637
-30,602
-109,006
-92,877
Net income available to common shareholders
-111,637
-111,637
-30,602
-109,006
-92,877
Basic EPS
-
-1.27
-0.52
-2.09
-2.21
Diluted EPS
-
-1.27
-0.52
-2.09
-2.21
Basic average shares
-
87,898
58,688
52,032
41,991
Diluted average shares
-
87,898
58,688
52,032
41,991
EBITDA
-
-110,526
-20,273
-99,193
-87,378